友和(02347.HK)推香港初創企業支援計劃 平台豁免加盟費用
友和集團(02347.HK)宣布正式推出香港初創企業支援計劃Y Incubator,作為友和集團商戶加盟模式的延伸,符合特定條件的初創企業在豁免上架費、年費及交易佣金加盟友和電子商務平台進行銷售。
集團表示,計劃旨在推動香港創業文化、鼓勵創新思維、助力本地初創企業開拓商機,以協助建立更蓬勃完整的香港初創企業生態,未來將積極發揮作為香港領先電子商務平台的獨特優勢,向加盟的初創企業輸出及分享豐富的線上線下融合零售業務的經驗及營運資源,預期有助初創企業可大幅減省營商成本,從而更有效調配其創業資源。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.